PTSD Interview Regarding Future Study Design and Equipment.

• Sponsor: Stephanie Sullivan (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05276115
• Collaborator: (none)
• Enrollment: 15
• Location: 1
• Anticipated Duration (Months): 12
• Patients Per Site Per Month: 1.3

Study Details

Study Description

Brief Summary

To gain insight and perspective unique to individuals with a diagnosis of PTSD, this study will utilize an experiential one-to-one interview format. During the interview, an investigator will walk the participants through several aspects of an ANS battery of tests, provide a tour and information about other equipment in the research lab and discuss tools and procedures associated with the application of chiropractic care. The aim of this research is to provide insight for future study designs that assess or provide care to individuals with PTSD.

Condition or Disease	Intervention/Treatment	Phase
Ptsd	Other: Interview

Study Design

• Study Type: Observational
• Anticipated Enrollment: 15 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: An Experiential, One-to-one Interview Process Examining the Perception of Research Assessments and Equipment From Individuals With Post-traumatic Stress Disorder (PTSD)
• Actual Study Start Date: Nov 18, 2021
• Anticipated Primary Completion Date: Nov 17, 2022
• Anticipated Study Completion Date: Nov 17, 2022

Outcome Measures

Primary Outcome Measures

1. Interview [1-2 hours]

   Notes and further insights regarding individuals with PTSD's feelings toward the research space and the research equipment.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 21 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Self-identify as having been diagnosed with PTSD.

• Between the ages 21-65 years old.

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Dr. Sid E. Williams Center for Chiropractic Research	Atlanta	Georgia	United States	30308

Sponsors and Collaborators

• Stephanie Sullivan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Stephanie Sullivan, Director, Life University
• ClinicalTrials.gov Identifier: NCT05276115
• Other Study ID Numbers: I-0018
• First Posted: Mar 11, 2022
• Last Update Posted: Mar 11, 2022
• Last Verified: Mar 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Mar 11, 2022